Get 15% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!

What key factors are powering the surge in the cat vaccine market right now?

The market size of cat vaccines has seen significant growth in recent times. It is projected to expand from $1.15 billion in 2024 to $1.26 billion in 2025, at a compound annual growth rate (CAGR) of 9.3%. The past growth can be credited to the emergence of new diseases in cats, a rise in the prevalence of animal diseases, an expansion in the livestock animal population, an increase in the number of companion animals, and a surge in zoonotic diseases.

How fast Is the cat vaccine market expected to grow, and what’s its future value?

In the upcoming years, considerable expansion is projected for the cat vaccine market, with an estimated value of $1.78 billion by 2029 and an impressive compound annual growth rate (CAGR) of 9.0%. Factors contributing to this upturn during the forecast phase include heightened pet adoption rates, augmented disposable income, escalating demand for professional vet services, initiatives from government and vet organizations, and a rising consciousness about pet health among consumers. Notable market trends during this time are likely to include the creation of superior cat vaccines, innovative and highly effective products, cutting-edge vaccine technologies, developments in combination vaccines and the advancement towards personalized vaccinations.

Get your cat vaccine market report here!

https://www.thebusinessresearchcompany.com/report/cat-vaccine-global-market-report

What are the leading drivers of growth in the cat vaccine market?

The cat vaccine market’s growth is anticipated to surge due to the increasing incidence of zoonotic diseases. Such diseases, which can be transferred from animals to humans, are triggered by pathogens like bacteria, viruses, fungi, and parasites. Direct contact, vectors, or interaction with a contaminated environment can facilitate the spread of zoonotic diseases that include Lyme disease, rabies, toxoplasmosis, salmonellosis, brucellosis, among others. Climate change, antibiotic resistance, and both illegal and legal wildlife trade contribute to the growing occurrence of zoonotic diseases. Cat vaccines can help manage these diseases by minimizing chances of transmission from cats to humans. This can be accomplished by immunizing cats against diseases such as toxoplasmosis and cat scratch fever. This preventive measure helps to lessen the effect of zoonotic diseases on human health, bolster public health initiatives, and guarantee a healthier habitat for pets and their caregivers. For instance, in February 2024, a report published by the UK Government stated that England had 335 verified Lyme disease cases in the fourth quarter of 2023, higher than the 273 cases noted during the corresponding period in 2022. Hence, the growing prevalence of zoonotic diseases is fuelling the cat vaccine market.

What are the key segments defining the cat vaccine market?

The cat vaccine market covered in this report is segmented –

1) By Vaccine Type: Modified Or Attenuated Live, Inactivated, Other Vaccine Types

2) By Disease Type: Feline Leukemia, Feline Panleukopenia, Feline Respiratory Diseases, Feline Rabies, Other Diseases

3) By Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines

4) By Route Of Administration: Injectables, Intranasal, Oral

5) By Distribution Channel: Veterinary Clinics, Pet Stores, Online Retailers

Subsegments:

1) By Modified or Attenuated Live: Feline Viral Rhinotracheitis (FVR) Vaccine, Feline Calicivirus (FCV) Vaccine, Feline Panleukopenia (FPV) Vaccine

2) By Inactivated: Inactivated Feline Leukemia Virus (FeLV) Vaccine, Inactivated Feline Infectious Peritonitis (FIP) Vaccine

3) By Other Vaccine Types: Recombinant Vaccines, DNA Vaccines, Subunit Vaccines, Combination Vaccines

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20526&type=smp

Who are the key players steering the development of the cat vaccine market?

Major companies operating in the cat vaccine market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale, Virbac, Neogen Corporation, Indian Immunologicals Ltd., Jinyu Bio-technology Co. Ltd., Ourofino Animal Health SA, Biogénesis Bagó SA, Valley Vet Supply, HIPRA Corporation, Bioveta AS, China Animal Husbandry Group, Veterinary Pharmaceutical Solutions, Torigen Pharmaceuticals Inc., KM Vet Pharm Sdn Bhd.

What emerging trends are influencing the growth of the cat vaccine market?

Prominent businesses in the cat vaccine market are concentrating on the creation of pioneering products like NOBIVAC NXT vaccines. These leverage advanced Ribonucleic acid (RNA)-particle technology to strengthen immune reactions, boost vaccine effectiveness, and offer targeted resistance to feline illnesses. Sophisticated Ribonucleic acid (RNA)-particle technology is a groundbreaking strategy that employs RNA molecules, encased in nanoparticles, to convey genetic directions to cells. This leads them to create certain proteins that prompt a targeted immune response. For example, in June 2024, MSD Animal Health Inc., an American pharmaceutical company, introduced The NOBIVAC NXT Rabies range, including NOBIVAC NXT Feline-3 Rabies and NOBIVAC NXT Canine-3 Rabies. These are an all-inclusive vaccination solution engineered to render effective protection against rabies in cats and dogs. NOBIVAC NXT vaccines are composed without adjuvants and preservatives, thereby improving their safety standing while preserving effectiveness. The vaccines incite both humoral (antibody-linked) and cell-mediated immune responses, offering thorough protection against the rabies virus.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20526

Which regions are most influential in expanding the cat vaccine market?

North America was the largest region in the cat vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cat vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Animal Health Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-health-global-market-report

Animal Drug Compounding Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-drug-compounding-global-market-report

Animal Wound Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-wound-care-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: